Machine learning’s impact on clinical trials
Machine learning is starting to show its potential in multiple fields. According to Gareth Baxendale, head of technology for the NIHR Clinical Research Network, clinical trials are no exception. He explains how machine learning holds the promise of faster and more effective trials – at every step of the process.
AI and Analytics 2
Healthcare IT news round-up
This months’ healthcare IT round-up includes various healthcare organisations entering into contracts with suppliers and about a trust’s new check-in kiosk.
Clinical Software
Now Healthcare Group lands multi-million investment
The company behind Dr Now and Now GP, Now Healthcare Group, has landed a multi-million pound investment to develop its artificial intelligence (AI) side.
Digital Patient 1
Mobile and app news in brief
This month’s mobile and app news in brief takes a look at AI, patient controlled records, and explores various health app comparison sites – an area NHS England is also getting into with its recently launched App Library.
News 1
Babylon Health raises £50m for AI diagnosis tool
Digital healthcare company, Babylon Health, have raised about £50 million to create an artificial intelligence (AI) diagnosis tool.
Digital Patient 3
Project launched to create artificial intelligence virtual GP
A research partnership has been given £250,000 to create a GP avatar that can help with minor ailments and alleviate pressures on GP practices.
News 6
Big Read: What does Google DeepMind want with the NHS?
The world’s most famous AI company, Google DeepMind, is making plenty of friends in the NHS. But what does the company want with our health service and should we be worried? Laura Stevens reports.
Feature 4
DeepMind Health is in talks with NHS trusts across England
DeepMind Health, is talking to trusts around England about implementing its technology. However, after cheap introductory deals, market rates would return.
AI and Analytics 1
“Inexcusable” mistakes made in Google DeepMind and Royal Free NHS data deal – study
An academic paper says “inexcusable” mistakes were made in the controversial deal between Google DeepMind Health and Royal Free to use patient data. Unsurprisingly, the AI company and NHS trust both disagree.
News 1
Genomics to hit mainstream with AI and $100 genome
A major technology partner for England’s 100k Genome project says the sequencing a genome could soon cost less than US$100.
News
